Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

D-serine counteracts temporal lobe epilepsy pathogenesis in rat models

Temporal lobe epilepsy (TLE) is the most common form of focal epilepsy1 and the most common type of drug-resistant epilepsy.2…

Read More

Masitinib: the first drug slowing progressive MS pathology

Multiple sclerosis (MS) is a long-life condition that affects the brain and spinal cord resulting in impaired vision, limb movement,…

Read More

AMX0035 shows promise as new ALS treatment

Amyotrophic lateral sclerosis (ALS) is an aggressive neurodegenerative disease that is fatal. The disease affects both upper and lower motor neurons…

Read More

A slipped-CAG DNA-binding molecule reverses Huntington’s disease repeat CAG mutation

Huntington’s disease (HD) is an autosomal dominant inherited neurodegenerative disease caused by a CAG trinucleotide repeat expansion in the huntingtin…

Read More

Plasma pTau181 could differentiate Alzheimer’s disease from other dementias

A recent study published in Nature Medicine has reported advances in the development of a blood test that could help…

Read More

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJNeurology is intended for healthcare professionals